Treatment with a melanocortin agonist improves abnormal lipid metabolism in streptozotocin-induced diabetic mice

Neuropeptides

Volumn 45, Issue 2, 2011, Pages 123-129

  Leckstrom, Arnold ^a   Lew, Pei San ^a   Poritsanos, Nicole J ^a   Mizuno, Tooru M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Central nervous system; Diabetes; FFA; Insulin; Lipolysis; Melanocortin

Indexed keywords

ANTIDIABETIC AGENT; CD36 ANTIGEN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; LIPOPROTEIN LIPASE; MELANOCORTIN RECEPTOR AGONIST; MTII; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES CONTROL; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; WHITE ADIPOSE TISSUE;

ALPHA-MSH; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHILD; DIABETES MELLITUS, EXPERIMENTAL; EATING; HUMANS; INSULIN; LEPTIN; LIPID METABOLISM; MALE; MELANOCORTINS; MICE; MICE, INBRED C57BL; TRIGLYCERIDES;

ANIMALIA; MUS;

EID: 79951511940     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2010.12.005     Document Type: Article

References (49)

1. Brito M.N., Brito N.A., Baro D.J., Song C.K., Bartness T.J. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007, 148:5339-5347.
2. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., Baetscher M., Cone R.D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141:3518-3521.
3. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., Van Der Ploeg L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26:97-102.
4. Chinookoswong N., Wang J.L., Shi Z.Q. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999, 48:1487-1492.
5. Coburn C.T., Knapp F.F., Febbraio M., Beets A.L., Silverstein R.L., Abumrad N.A. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 2000, 275:32523-32529.
6. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 8:571-578.
7. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 2007, 27:79-101.
8. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
9. Haemmerle G., Zimmermann R., Hayn M., Theussl C., Waeg G., Wagner E., Sattler W., Magin T.M., Wagner E.F., Zechner R. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem. 2002, 277:4806-4815.
10. Havel P.J., Hahn T.M., Sindelar D.K., Baskin D.G., Dallman M.F., Weigle D.S., Schwartz M.W. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 2000, 49:244-252.
11. Havel P.J., Uriu-Hare J.Y., Liu T., Stanhope K.L., Stern J.S., Keen C.L., Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am. J. Physiol. 1998, 274:R1482-1491.
12. Hidaka S., Yoshimatsu H., Kondou S., Tsuruta Y., Oka K., Noguchi H., Okamoto K., Sakino H., Teshima Y., Okeda T., Sakata T. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. Faseb J. 2002, 16:509-518.
13. Hohmann J.G., Teal T.H., Clifton D.K., Davis J., Hruby V.J., Han G., Steiner R.A. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R50-59.
14. Huo L., Gamber K., Greeley S., Silva J., Huntoon N., Leng X.H., Bjorbaek C. Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 2009, 9:537-547.
15. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
16. Idzior-Walus B., Mattock M.B., Solnica B., Stevens L., Fuller J.H. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM complications study. Diabet. Med. 2001, 18:786-796.
17. Imperatore G., Cadwell B.L., Geiss L., Saadinne J.B., Williams D.E., Ford E.S., Thompson T.J., Narayan K.M., Gregg E.W. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: national health and nutrition examination surveys, 1971-2000. Am. J. Epidemiol. 2004, 160:531-539.
18. Jenkins C.M., Mancuso D.J., Yan W., Sims H.F., Gibson B., Gross R.W. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 2004, 279:48968-48975.
19. Kask A., Mutulis F., Muceniece R., Pahkla R., Mutule I., Wikberg J.E., Rago L., Schioth H.B. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 1998, 139:5006-5014.
20. Kershaw E.E., Hamm J.K., Verhagen L.A., Peroni O., Katic M., Flier J.S. Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006, 55:148-157.
21. Kim E.M., Grace M.K., Welch C.C., Billington C.J., Levine A.S. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 1999, 276:R1320-1326.
22. Kim Y.W., Choi D.W., Park Y.H., Huh J.Y., Won K.C., Choi K.H., Park S.Y., Kim J.Y., Lee S.K. Leptin-like effects of MTII are augmented in MSG-obese rats. Regul. Pept. 2005, 127:63-70.
23. Lee M., Kim A., Chua S.C., Obici S., Wardlaw S.L. Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E121-131.
24. Li G., Mobbs C.V., Scarpace P.J. Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker Rats. Diabetes 2003, 52:1951-1957.
25. Li G., Zhang Y., Wilsey J.T., Scarpace P.J. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats. Diabetologia 2005, 48:2376-2385.
26. Lin C.Y., Higginbotham D.A., Judd R.L., White B.D. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E1084-1091.
27. Maness L.M., Kastin A.J., Farrell C.L., Banks W.A. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 1998, 139:4556-4562.
28. Merkel M., Eckel R.H., Goldberg I.J. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 2002, 43:1997-2006.
29. Mizuno T.M., Kelley K.A., Pasinetti G.M., Roberts J.L., Mobbs C.V. Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 2003, 52:2675-2683.
30. Mizuno T.M., Kleopoulos S.P., Bergen H.T., Roberts J.L., Priest C.A., Mobbs C.V. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin [published erratum appears in Diabetes 1998 Apr;47(4):696]. Diabetes 1998, 47:294-297.
31. Mizuno T.M., Makimura H., Silverstein J., Roberts J.L., Lopingco T., Mobbs C.V. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology 1999, 140:4551-4557.
32. Mizuno T.M., Mobbs C.V. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 1999, 140:814-817.
33. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., Pfluger P.T., Castaneda T.R., Neschen S., Hofmann S.M., Howles P.N., Morgan D.A., Benoit S.C., Szanto I., Schrott B., Schurmann A., Joost H.G., Hammond C., Hui D.Y., Woods S.C., Rahmouni K., Butler A.A., Farooqi I.S., O'Rahilly S., Rohner-Jeanrenaud F., Tschop M.H. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 2007, 117:3475-3488.
34. O'Brien T., Nguyen T.T., Zimmerman B.R. Hyperlipidemia and diabetes mellitus. Mayo. Clin. Proc. 1998, 73:969-976.
35. Obici S., Feng Z., Tan J., Liu L., Karkanias G., Rossetti L. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 2001, 108:1079-1085.
36. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
37. Poritsanos N.J., Wong D., Vrontakis M.E., Mizuno T.M. Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin. Biochem. Biophys. Res. Commun. 2008, 376:384-388.
38. Reaven G.M., Greenfield M.S. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 1981, 30:66-75.
39. Savontaus E., Breen T.L., Kim A., Yang L.M., Chua S.C., Wardlaw S.L. Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice. Endocrinology 2004, 145:3881-3891.
40. Schioth H.B., Muceniece R., Mutulis F., Prusis P., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E. Selectivity of cyclic [d-Nal7] and [d-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides 1997, 18:1009-1013.
41. Schwartz M.W., Seeley R.J., Woods S.C., Weigle D.S., Campfield L.A., Burn P., Baskin D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997, 46:2119-2123.
42. Shrestha Y.B., Vaughan C.H., Smith B.J., Song C.K., Baro D.J., Bartness T.J. Central melanocortin stimulation increases phosphorylated perilipin A and hormone-sensitive lipase in adipose tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R140-149.
43. Sztalryd C., Kraemer F.B. Regulation of hormone-sensitive lipase in streptozotocin-induced diabetic rats. Metabolism 1995, 44:1391-1396.
44. Thornton J.E., Cheung C.C., Clifton D.K., Steiner R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997, 138:5063-5066.
45. Tsujita T. Basal lipolysis in epididymal fat cells from streptozotocin-induced diabetic rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2006, 52:47-53.
46. Villena J.A., Roy S., Sarkadi-Nagy E., Kim K.H., Sul H.S. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J. Biol. Chem. 2004, 279:47066-47075.
47. Weis U., Turner B., Gibney J., Watts G.F., Burke V., Shaw K.M., Cummings M.H. Long-term predictors of coronary artery disease and mortality in type 1 diabetes. Qjm 2001, 94:623-630.
48. Yu X., Park B.H., Wang M.Y., Wang Z.V., Unger R.H. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc. Natl. Acad. Sci. USA 2008, 105:14070-14075.
49. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386.